Volume 6 Supplement 1

15thPaediatric Rheumatology European Society (PreS) Congress

Open Access

The Damage Associated Molecular Pattern (DAMP) molecule S100A12 induces pro-inflammatory responses in monocytes via innate immunity signalling pathways

  • H Wittkowski1,
  • D Viemann1,
  • A Lueken2,
  • K Barczyk2,
  • T Vogl2,
  • J Roth2 and
  • D Foell1
Pediatric Rheumatology20086(Suppl 1):P2

https://doi.org/10.1186/1546-0096-6-S1-P2

Published: 15 September 2008

Background

In a previous study, we demonstrated excessive activation of neutrophils leading to high concentrations of S100A12, a member of the damage-associated molecular pattern molecules (DAMP), in systemic-onset juvenile idiopathic arthritis (SOJIA) which is not found in other inflammatory diseases. Binding to the Receptor for Advanced Glycation Endproducts (RAGE) has been shown but exact molecular mechanisms of S100A12 leading to pro-inflammatory responses in immune cells are still lacking.

Methods

We analyzed the S100A12-induced expression pattern in human monocytes by microarray technology. Results were independently confirmed by real-time polymerase chain reaction (PCR) and flow cytometry. Additionally we used different knock down approaches of signalling pathways to identify common inflammatory and ligand-specific effects on gene expression changes.

Results

Functional clustering indicated induction of monocytic properties such as pro-inflammatory activation, chemotaxis, and repression of apoptosis. 43% of 745 S100A12-induced genes are also up-regulated by LPS already indicating a strong overlap. Inhibition revealed TLR-4 and NFκB as key signalling pathways.

Conclusion

In terms of gene expression changes S100A12 shows strong overlaps with LPS. Similar to LPS a significant portion of gene expression changes induced by S100A12 are dependent on TLR4 and NF-kB. Additionally, S100A12 activates an at least second strong signalling pathway which might be a RAGE-dependent cascade.

Authors’ Affiliations

(1)
Department of Pediatrics, University Hospital Muenster
(2)
University Hospital Muenster, Institute of Immunology

Copyright

© Wittkowski et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd.

Advertisement